Gvanetidin

Gvanetidin
(IUPAC) ime
	2-[2-(azokan-1-il)etil]gvanidin
Klinički podaci
AHFS/Drugs.com	Mikromedeks, detaljne potrošačke informacije
MedlinePlus	a600027
Identifikatori
CAS broj	645-43-2
ATC kod	C02CC02 S01EX01
PubChem	3518
DrugBank	DB01170
ChemSpider	3398
UNII	5UBY8Y002G
KEGG	D08030
ChEBI	CHEBI:5557
ChEMBL	CHEMBL765
Hemijski podaci
Formula	C10H22N4
Mol. masa	198,309 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C10H22N4/c11-10(12)13-6-9-14-7-4-2-1-3-5-8-14/h1-9H2,(H4,11,12,13) ; Key: ACGDKVXYNVEAGU-UHFFFAOYSA-N
Farmakokinetički podaci
Poluvreme eliminacije	1,5 dana
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Gvanetidin je antihipertenziv koji umanjuje otpuštanje kateholamina, poput norepinefrina. Gvanetidin se transportuje kroz simpatetičke nervne membrane istim mehanizmom kojim se transportuje norepinefrin. Unos leka je esencijalan za njegovo dejstvo. Nakon ulaza gvanetidina u nerve, on se koncentruje u transmisionim vezikulama, gde zamenjuje norepinefrin.

Hemija

Početni materijal za sintezu gvanetidina, azocin se alkiluje hloroacetonitrilom. Nastali 1-azocinilacetonitril se može redukovati u 1-(2-aminoetil)azocin koristeći litijum aluminijum hidrid kao reduktant. Ovo jedinjenje reaguje sa S-metiltiourejom formirajući gvanetidin.^[6]^[7]^[8]

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ R.P. Mull, U.S. Patent 2.928.829 (1960).
↑ R.P. Mull, U.S. Patent 3.006.913 (1961).
↑ R.P. Mull, U.S. Patent 3.055.882 (1962).

Vanjske veze

	Portal Medicina
	Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[6] R.P. Mull, U.S. Patent 2.928.829 (1960).

[7] R.P. Mull, U.S. Patent 3.006.913 (1961).

[8] R.P. Mull, U.S. Patent 3.055.882 (1962).

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]